Pilot Study Evaluating the Efficacy and Safety of Metformin in Melanoma

NCT01840007 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Melanoma (Stage IIIC Non-résécable or no Surgically Curable or Stage IV With Classification AJCC)

Interventions

DRUG: Metformin Group

Sponsor

Centre Hospitalier Universitaire de Nice